NK
Narendra Kumar Dalawat
About Narendra Kumar Dalawat
Data last updated:
Narendra Kumar Dalawat is a Director at Ceza Formulations Private Limited (since 2016). The company operates in Pharma. Ceza Formulations Private Limited reported revenue of ₹3.60 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 11 Jul 2016 | 1999 | ₹3.60 Cr (FY 2024) | Active |
Board colleagues of Narendra Kumar Dalawat
| Name | DIN | Company | Designation |
|---|---|---|---|
| Anil Kumar Vyas | 02417592 | Ceza Formulations Private Limited | Director |
| Krishnakant Mundra | 06988783 | Ceza Formulations Private Limited | Director |
| Mimoh Paliwal | 06988784 | Ceza Formulations Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Narendra Kumar Dalawat
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Narendra Kumar Dalawat
Narendra Kumar Dalawat currently holds 1 directorship: Ceza Formulations Private Limited (Director, since 11 Jul 2016, revenue ₹3.60 Cr (FY 2024)).
Narendra Kumar Dalawat was first appointed on 11 Jul 2016 as Director at Ceza Formulations Private Limited.
The current boards of Narendra Kumar Dalawat's companies include Anil Kumar Vyas (Ceza Formulations Private Limited), Krishnakant Mundra (Ceza Formulations Private Limited), Mimoh Paliwal (Ceza Formulations Private Limited).